Rik Joos Selected Research

Infliximab (Remicade)

9/2007

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rik Joos Research Topics

Disease

11	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021 - 07/2004
3	Arthritis (Polyarthritis) 11/2021 - 12/2012
3	Body Weight (Weight, Body) 01/2021 - 02/2005
3	Infections 02/2020 - 12/2012
2	Pain (Aches) 01/2021 - 01/2019
2	Myositis (Idiopathic Inflammatory Myopathies) 05/2018 - 02/2016
2	Rheumatoid Arthritis 03/2017 - 04/2015
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2022
1	Chorea (Rheumatic Chorea) 10/2022
1	Low Back Pain (Lumbago) 12/2021
1	Ankylosing Spondylitis 11/2021
1	Axial Spondyloarthritis 11/2021
1	Diphtheria 02/2020
1	Tetanus 02/2020
1	Bacterial Meningitis 01/2019
1	Meningitis 01/2019
1	Tendinopathy (Tendonitis) 05/2018
1	Vasculitis (Vasculitides) 05/2018
1	Injection Site Reaction 01/2018
1	Joint Diseases (Joint Disease) 03/2017
1	Synovitis 11/2016
1	Dermatomyositis (Dermatopolymyositis) 02/2016
1	Fever (Fevers) 12/2012
1	Neutropenia 12/2012
1	Psoriatic Arthritis 10/2012
1	Hyperplasia 08/2006

Drug/Important Bio-Agent (IBA)

7	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 07/2004
4	tocilizumab (atlizumab)FDA Link 01/2021 - 12/2012
3	GlucocorticoidsIBA 03/2017 - 12/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 02/2020
2	GadoliniumIBA 12/2021 - 11/2016
2	Antirheumatic Agents (DMARD)IBA 02/2020 - 03/2017
2	Abatacept (Orencia)FDA Link 02/2020 - 01/2018
2	C-Reactive ProteinIBA 01/2018 - 03/2017
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2006
1	Rituximab (Mabthera)FDA Link 10/2022
1	Biological ProductsIBA 11/2021
1	ametantrone (HAQ)IBA 01/2021
1	VaccinesIBA 02/2020
1	Diphtheria-Tetanus VaccineIBA 02/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	BuffersIBA 01/2019
1	Interferon Type IIBA 01/2019
1	InterferonsIBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2018
1	Isotretinoin (Accutane)FDA LinkGeneric 05/2018
1	golimumab FDA Link 01/2018
1	canakinumab FDA Link 01/2017
1	Pharmaceutical PreparationsIBA 02/2016
1	Prednisone (Sone)FDA LinkGeneric 02/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2016
1	Transaminases (Aminotransferases)IBA 12/2012
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2012
1	apremilastIBA 10/2012
1	Infliximab (Remicade)FDA Link 09/2007
1	Chitinase-3-Like Protein 1IBA 08/2006
1	Meloxicam (Mobic)FDA LinkGeneric 02/2005
1	Naproxen (Naprosyn)FDA LinkGeneric 02/2005
1	SuspensionsIBA 02/2005

Therapy/Procedure

4	Therapeutics 10/2022 - 02/2005
1	Injections 01/2018
1	Remission Induction 03/2017
1	Time-to-Treatment 02/2016